Status:
RECRUITING
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
Lead Sponsor:
Johns Hopkins Bloomberg School of Public Health
Collaborating Sponsors:
National Institutes of Health (NIH)
Baltimore City Health Department
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Through the proposed Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement (SCOPE) study, the investigators will design and evaluate an overdose prevention and HIV prevention stud...
Detailed Description
specific study aims are: 1. To prepare the drug-checking technology for deployment in the community through a three-phase process. 1. To calibrate drug-checking technology through testing samples...
Eligibility Criteria
Inclusion
- 18 years or older,
- self-reports having used illicit stimulants or opioids at least once in the past 3 months,
- self-reports being HIV negative
- reports injection drug use in the past 6 months OR reports at least one of the following indicators of sexual HIV risk exposure in the past 6 months:
- Sexually Transmitted Infection (STI) diagnosis in the past 6 months
- "Condom-less" vaginal or anal sex in the past 6 months
- Willing to provide a urine sample for urine drug screening of substances
- Willing to undergo rapid HIV testing
- Willing to undergo STI testing
Exclusion
- Determined to be too high or drunk or cognitively impaired, less than 18 years of age
- unwilling to provide all required biological specimens (Phase 3 only)
- unwilling/unable to give consent
Key Trial Info
Start Date :
July 28 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05977881
Start Date
July 28 2023
End Date
June 30 2026
Last Update
June 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins School of Public Health
Baltimore, Maryland, United States, 21205